ID-4708

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

ID-4708 is a butyrophenone neuroleptic agent. It has the same structure as for trifluperidol but differs by the incorporation of an aniline amino group into the butyrophenone sidechain. Whereas trifluperidol is a Belgian drug developed at Janssen Pharmaceuticals, ID-4708 was developed by a Japanese company called Sumitomo Chemical in the 1970’s. ID-4708 when given at low doses reduced ambulation, while at higher doses defecation was inhibited.

ID-4708 is a butyrophenone neuroleptic agent. It has the same structure as for trifluperidol but differs by the incorporation of an aniline amino group into the butyrophenone sidechain. Whereas trifluperidol is a Belgian drug developed at Janssen Pharmaceuticals, ID-4708 was developed by a Japanese company called Sumitomo Chemical in the 1970’s. ID-4708 when given at low doses reduced ambulation, while at higher doses defecation was inhibited.

Synthesis

The chemical synthesis of ID-4708 was reported: 2-Acetylbutyrolactone [517-23-7] (1) 4-Fluoro-2-nitrobenzoic acid [394-01-4] (2) 4-Fluoro-2-nitrobenzoyl chloride [57750-82-0] (3) 3-(4-Fluoro-2-nitrobenzoyl)oxolan-2-one [62513-47-7] (4) 4-Bromo-1-(4-fluoro-2-nitrophenyl)butan-1-one [62513-48-8] (5) 2-(3-Bromopropyl)-2-(4-fluoro-2-nitrophenyl)-1,3-dioxolane [62513-50-2] (6) 4-hydroxy-4-(3-trifluoromethylphenyl)piperidine [2249-28-7] (7) PC86735492 (8) PC70620175 (9)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370481976 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.